Vaccine makers hit back against patent claims

28-07-2022

Staff Writer

Vaccine makers hit back against patent claims

shutterstock_1985962832_Marco Lazzarini

German biotech and its US big pharma partner file counter complaint | Under-fire pair say they didn’t infringe patents | Claims reject earlier suit as an attempt to profit through legal threats.


CureVac, BioNTech, patent infringement, COVID-19, mRNA, vaccines, vaccination, messenger ribonucleic acid, Comirnaty, US, Germany, Americas, Europe

LSIPR